Drug that delays onset of type 1 diabetes gets approval in US
New ScientistJUL 2022
This development not only promises to reduce the frequency of treatments, but also to significantly reduce the risk of long-term health complications. Additionally, it could free millions of Type 1 diabetes patients from the constant need for glucose monitoring, thereby easing both physical and mental burdens of the condition.
While this treatment could be promising, accessibility and affordability remain critical issues. Only when older, cheaper versions of the drug are discontinued and unhealthy competition is checked can these game-changing insulins replace existing treatments and improve diabetics' lives.